IGV-001
- Generic Name
- IGV-001
Pilot Immunotherapy Trial for Recurrent Malignant Gliomas
Phase 1
Completed
- Conditions
- Malignant Glioma of Brain
- Interventions
- Device: biodiffusion chamber
- First Posted Date
- 2012-03-12
- Last Posted Date
- 2025-05-02
- Target Recruit Count
- 13
- Registration Number
- NCT01550523
- Locations
- 🇺🇸
Thomas Jefferson University Hospital; Jefferson Hospital for Neurosciences, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath